TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 149.00
+0.50 (0.34%)
Aug 19, 2026, 1:30 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 8.77 billion as of August 18, 2026. Its market cap has increased by 73.28% in one year.
Market Cap
8.77B
Enterprise Value
7.59B
Revenue
701.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
149.00
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 8.77B, an increase of 540.99%. That is a compound annual growth rate of 13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 8.77B | -14.16% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 11.94B |
| Tanvex BioPharma | 9.88B |
| AP Biosciences | 9.84B |
| Polaris Group | 9.29B |
| PharmaEngine | 8.49B |
| Locus Cell | 7.45B |
| Adimmune | 7.27B |
| Acepodia | 6.88B |